BindingDB logo
myBDB logout

14 articles for thisTarget

The following articles (labelled with PubMed ID or TBD) are for your review
PMIDDataArticle TitleOrganization
28197313 17 From Dynamic Combinatorial Chemistry toEBI Universit£ Libre de Bruxelles (ULB)
27537923 31 Novel bis-arylalkylamines as myeloperoxidase inhibitors: Design, synthesis, and structure-activity relationship study.EBI Universit£ Libre de Bruxelles
26509551 31 Discovery of 2-(6-(5-Chloro-2-methoxyphenyl)-4-oxo-2-thioxo-3,4-dihydropyrimidin-1(2H)-yl)acetamide (PF-06282999): A Highly Selective Mechanism-Based Myeloperoxidase Inhibitor for the Treatment of Cardiovascular Diseases.EBI Pfizer Inc.
25438766 38 Inhibition of myeloperoxidase: evaluation of 2H-indazoles and 1H-indazolones.EBI University of California
23581551 75 Design, synthesis, and structure-activity relationship studies of novel 3-alkylindole derivatives as selective and highly potent myeloperoxidase inhibitors.EBI Universit£ Libre de Bruxelles
22793255 16 Evaluation of new scaffolds of myeloperoxidase inhibitors by rational design combined with high-throughput virtual screening.EBI Universit£ Libre de Bruxelles
18063373 11 Conception of myeloperoxidase inhibitors derived from flufenamic acid by computational docking and structure modification.EBI Universit£ Libre de Bruxelles
21090682 48 Structure-based design, synthesis, and pharmacological evaluation of 3-(aminoalkyl)-5-fluoroindoles as myeloperoxidase inhibitors.EBI Universite£? Libre de Bruxelles
1732557 20 Improvements in the minimum binding sequence of C5a: examination of His-67.EBI Abbott Laboratories
1372359 3 Novel benzothiophene-, benzofuran-, and naphthalenecarboxamidotetrazoles as potential antiallergy agents.EBI Warner-Lambert Company
20565336 24 Design, synthesis and biological evaluation of CB1 cannabinoid receptor ligands derived from the 1,5-diarylpyrazole scaffold.BDB NanChang University School of Pharmaceutical Science